The global next-generation sequencing data analysis market size is expected to reach USD 1.72 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.02% from 2021 to 2028. Key drivers contributing to the market expansion include the growing adoption of sequencing platforms for clinical diagnosis because of a significant reduction in the cost of installation.
Furthermore,
the easy availability of genomic and proteomic data is expected to create
lucrative growth opportunities for this market during the forecast period. In
addition, a decrease in the cost of sequencing is expected to increase the
adoption rate of NGS, which, in turn, is likely to boost the market
growth. The availability of tools such as Agilent’s HaloPlex capture system and
Targeted Methyl-Seq platform from EpiGentek Group Inc. has helped in the
determination of DNA methylation profiles in individual genomes.
The
COVID-19 pandemic has accelerated the usage of NGS and created a massive
requirement for NGS data analysis solutions. The NGS tools were able to
generate a considerable amount of data for researchers to study and analyze the
pathogenesis. The professionals from academia, industry and government have
used sequencing and data analysis technology to assist in understanding the
characteristics, processes, and phylogenetics ofSARS‐CoV‐2.
In
the NGS commercial software product segment, the analytical software segment is
expected to register the fastest CAGR over the forecast period owing to the
high demand and an increase in awareness regarding sequencing technologies. A
large amount of data generated through NGS needs management solutions and
platforms, which results in high demand for such tools and algorithms.
Major
market participants such as QIAGEN, Thermo Fisher Scientific, Roche, and
Illumina have undertaken strategic initiatives to strengthen their position in
the market. For instance, in January 2021, Transnetyx, Inc. collaborated with
One Codex to provide end-to-end analysis and microbiome sequencing services.
This is expected to offer affordable sequencing analysis services to
researchers.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-data-analysis-market
Next-generation
Sequencing Data Analysis Market Report Highlights
- In terms of
product, services dominated the market in 2020. Although NGS is
advantageous in terms of affordability and speed, many research entities
are unable to adopt it owing to a lack of sufficient computational
infrastructure and skilled professionals to analyze the generated
information. Therefore, institutions that lack provision for data
interpretation, analysis, and management adopt platforms and services
offered by other players in the market
- Based on
workflow, the tertiary analysis segment held the largest revenue share in
2020 as it accounts for the most complex and important step of NGS, which
is directly linked with the interpretation of results. The commercial
availability of tools and software, including CIViC, SIFT, and PolyPhen,
for annotation and variant interpretation also contributes to the segment
growth
- The in-house
mode segment dominated the market in 2020 and is expected to maintain its
lead during the forecast period. The outsourced mode segment is expected
to exhibit the fastest CAGR over the forecast period owing to the time and
cost benefits associated with this mode and the presence of key players
offering data analysis services. SciBerge.Kfm, a Germany based research
company, offers outsourced services for computational analysis of NGS
information
- By read
length, the short-read sequencing segment led the market in 2020 owing to
the wide adoption of short-read sequencing techniques, their
inexpensiveness, the availability of a number of tools and algorithms, and
the ability to work with fragment DNA. HISAT2, Minimap2, BWA, STAR,
Bowtie2, and TopHat alignment tools are commonly used to analyze
short-read sequencing data
- The academic
research end-use segment held the largest revenue share in 2020. A
decrease in the cost of NGS technology has increased the usage of NGS
software and data analysis platforms by various academic institutions and
research centers for their projects that require data interpretation
- Europe dominated
the global market in 2020 owing to the high adoption of next-generation
sequencing for analysis ofCOVID-19 samples in research as well as clinical
settings, along with the rise in demand for personalized medicine
Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-data-analysis-market/request/rs1
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment